Menu
GeneBe

PAX5

paired box 5, the group of PRD class homeoboxes and pseudogenes|Paired boxes|MicroRNA protein coding host genes

Basic information

Region (hg38): 9:36833268-37034268

Links

ENSG00000196092NCBI:5079OMIM:167414HGNC:8619Uniprot:Q02548AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • leukemia, acute lymphoblastic, susceptibility to, 3 (Limited), mode of inheritance: AD
  • leukemia, acute lymphoblastic, susceptibility to, 3 (Moderate), mode of inheritance: AD
  • PAX5-related B lymphopenia and autism spectrum disorder (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Leukemia, acute lymphoblastic, susceptibility to, 3ADOncologicAwareness of B-ALL risk may allow surveillance and early detection and management, which may benefit morbidity and mortality; HSCT has been describedOncologic24013638

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PAX5 gene.

  • not provided (87 variants)
  • not specified (35 variants)
  • Acute lymphoid leukemia (17 variants)
  • Inborn genetic diseases (13 variants)
  • Leukemia, acute lymphoblastic, susceptibility to, 3 (11 variants)
  • Neurodevelopmental disorder (2 variants)
  • PAX5-related condition (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PAX5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
13
clinvar
15
missense
5
clinvar
37
clinvar
6
clinvar
5
clinvar
53
nonsense
3
clinvar
1
clinvar
4
start loss
0
frameshift
6
clinvar
6
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
splice region
2
5
7
non coding
18
clinvar
34
clinvar
52
Total 0 15 42 37 39

Highest pathogenic variant AF is 0.00000661

Variants in PAX5

This is a list of pathogenic ClinVar variants found in the PAX5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-36840330-C-T Benign (Mar 20, 2019)1226046
9-36840449-G-A Likely benign (Feb 28, 2019)1254811
9-36840544-C-T PAX5-related disorder Likely benign (Nov 16, 2020)3036751
9-36840545-G-A not specified not provided (Sep 19, 2013)133372
9-36840567-C-T Leukemia, acute lymphoblastic, susceptibility to, 3 • not specified Uncertain significance (Jan 12, 2021)620603
9-36840573-T-C Uncertain significance (Jul 13, 2022)1878883
9-36840575-G-A not specified Likely benign (Jan 02, 2019)1336961
9-36840584-G-A Likely benign (Apr 14, 2023)2975426
9-36840587-T-G Likely benign (May 20, 2023)745370
9-36840599-G-A not specified Likely benign (Jun 14, 2023)1337669
9-36840607-G-A Neurodevelopmental disorder Uncertain significance (Oct 11, 2022)1210155
9-36840610-C-T not specified Uncertain significance (Oct 14, 2021)1337759
9-36840611-G-T PAX5-related disorder Uncertain significance (Nov 29, 2022)2635404
9-36840617-G-A PAX5-related disorder Uncertain significance (Dec 05, 2023)3055435
9-36840626-G-A not specified Benign (Jan 31, 2024)134998
9-36840629-G-A PAX5-related disorder Likely benign (Jan 06, 2024)2875488
9-36840647-C-A Likely benign (Dec 25, 2023)2869733
9-36840647-C-T not specified Benign (Dec 03, 2023)1336248
9-36840648-G-A Likely benign (Jan 04, 2024)1971724
9-36840688-C-T Benign (Apr 16, 2019)1234553
9-36840709-C-A Likely benign (Jun 10, 2019)1254224
9-36840730-C-G Benign (Feb 28, 2019)1245021
9-36846596-C-T Benign (Feb 28, 2019)1243970
9-36846830-C-T Likely benign (Nov 15, 2023)1971929
9-36846831-G-A not specified Likely benign (Jan 11, 2024)436160

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PAX5protein_codingprotein_codingENST00000358127 10200832
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9980.002021255090101255190.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.451392480.5610.00001512484
Missense in Polyphen39108.850.358291066
Synonymous-0.4691121061.060.00000732801
Loss of Function3.95018.10.007.69e-7218

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.0002020.000199
East Asian0.0001120.000109
Finnish0.00004880.0000464
European (Non-Finnish)0.00001820.0000176
Middle Eastern0.0001120.000109
South Asian0.00006660.0000654
Other0.0001690.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: May play an important role in B-cell differentiation as well as neural development and spermatogenesis. Involved in the regulation of the CD19 gene, a B-lymphoid-specific target gene.;
Disease
DISEASE: Note=A chromosomal aberration involving PAX5 is a cause of acute lymphoblastic leukemia. Translocation t(9;18)(p13;q11.2) with ZNF521. Translocation t(9;3)(p13;p14.1) with FOXP1. Translocation t(9;12)(p13;p13) with ETV6. {ECO:0000269|PubMed:17344859}.; DISEASE: Leukemia, acute lymphoblastic, 3 (ALL3) [MIM:613065]: A subtype of acute leukemia, a cancer of the white blood cells. Acute lymphoblastic anemia is a malignant disease of bone marrow and the most common malignancy diagnosed in children. The malignant cells are lymphoid precursor cells (lymphoblasts) that are arrested in an early stage of development. The lymphoblasts replace the normal marrow elements, resulting in a marked decrease in the production of normal blood cells. Consequently, anemia, thrombocytopenia, and neutropenia occur to varying degrees. The lymphoblasts also proliferate in organs other than the marrow, particularly the liver, spleen, and lymphnodes. {ECO:0000269|PubMed:24013638}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Transcriptional misregulation in cancer - Homo sapiens (human);Prion disease pathway;ID signaling pathway;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;RUNX1 regulates transcription of genes involved in BCR signaling;C-MYB transcription factor network;ID;Transcriptional regulation by RUNX1 (Consensus)

Recessive Scores

pRec
0.0809

Intolerance Scores

loftool
0.0277
rvis_EVS
0
rvis_percentile_EVS
53.73

Haploinsufficiency Scores

pHI
0.437
hipred
Y
hipred_score
0.875
ghis
0.410

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pax5
Phenotype
neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; craniofacial phenotype;

Zebrafish Information Network

Gene name
pax5
Affected structure
hair cell
Phenotype tag
abnormal
Phenotype quality
apoptotic

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;humoral immune response;multicellular organism development;spermatogenesis;aging;animal organ morphogenesis;lateral ventricle development;cerebral cortex development;adult behavior;skeletal muscle cell differentiation;positive regulation of transcription by RNA polymerase II;embryonic cranial skeleton morphogenesis;regulation of B cell receptor signaling pathway;negative regulation of histone H3-K9 methylation
Cellular component
fibrillar center;nucleoplasm;cytosol;intracellular membrane-bounded organelle
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding